Growth Metrics

Fulgent Genetics (FLGT) Other Operating Expenses (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Other Operating Expenses for 11 consecutive years, with $13.0 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 12.78% to $13.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.2 million through Dec 2025, up 67.39% year-over-year, with the annual reading at $51.4 million for FY2025, 16.27% up from the prior year.
  • Other Operating Expenses hit $13.0 million in Q4 2025 for Fulgent Genetics, up from -$6.5 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $132.7 million in Q4 2023 to a low of -$23.8 million in Q4 2022.
  • Historically, Other Operating Expenses has averaged $25.8 million across 5 years, with a median of $11.3 million in 2024.
  • Biggest five-year swings in Other Operating Expenses: surged 2454.33% in 2021 and later crashed 219.13% in 2024.
  • Year by year, Other Operating Expenses stood at $89.7 million in 2021, then crashed by 126.57% to -$23.8 million in 2022, then surged by 656.78% to $132.7 million in 2023, then crashed by 91.31% to $11.5 million in 2024, then increased by 12.78% to $13.0 million in 2025.
  • Business Quant data shows Other Operating Expenses for FLGT at $13.0 million in Q4 2025, -$6.5 million in Q3 2025, and $14.3 million in Q2 2025.